Showing posts with label patents. Show all posts
Showing posts with label patents. Show all posts

May 09, 2008

Intellectual copyright: many businesses will give ideas away

Future of futurists bright because future trends soon become the past. Giving away intellectual capital. Wikipedia and YouTube world. Intellectual property only has power when released and used by others. Future is about giving away knowledge and ideas. Future of universities and research institutions, future of music and music industry. How to understand future trends. Conference keynote speaker and Futurist Dr Patrick Dixon.

April 24, 2008

Spying at Work -- espionage, who, how, why, how to stop it

Spying at work, industrial espionage, how data is stolen, data leakage, discovery before patent protection, intellectual capital theft, client data losses, blackmail of banks after penetration of data security systems, databases and confidential information. Why attacks are common. Methods used to attack corporations. Why greatest security risks are your own employees: own staff leaving or leaking information while still in your corporation. Bugging devices detection, remote listening devices. Big Brother is watching you. MI5, CIA, KGB have powers to intercept phone calls, e-mail, video, fax and data transmissions to prevent crime, terrorism and subversive activity, and similar technology can be used to target legitimate business. Data protection and confidentiality. Steps business leaders need to take to improve own security and manage risk. Rule Number 1 is be aware that greatest risks are usually internal. Video by keynote conference speaker Dr Patrick Dixon, Futurist and author of 12 books on global trends including Futurewise and Building a Better Business.
Security, data loss, intellectual capital, patents, theft, industrial espionage, threat, risk, corporations, databases,, intercept, listening devices, bugging detection, spying corporations, protection information

March 27, 2008

Future of the pharmaceutical industry -- conference ...

Generic competition and product recalls. Patent expiry and intellectual property protection. Legal challenges and research scandals. Biogenerics and large molecule therapeutics. Cellular mechanisms of disease. Unmet needs. Government purchasing policies and insurance cover. Online pharmacy price pressures. Search for new blockbusters. Chronic disease and orphan therapies. Rheumatoid and asthma. Antibiotics and multiple resistance problems. Search for powerful antiviral therapy. Future health funding and ageing populations. Contrast with emerging nations. Treatment access and justice issues. Pharmacogenomics and gene prophecy. Ethical issues. HIV and AIDS.